Search research articles
Contact Us
Filters
Showing results (11-20 of 133) with videos related to
Page
of 14
Sort By:
Cancers
|
July 2, 2021
Antibody-Drug Conjugates for the Treatment of Breast Cancer
Chiara Corti, Federica Giugliano, Eleonora Nicolò, et al.
Cancer Treatment and Research
|
January 4, 2024
New Concepts in Cardio-Oncology
Paola Zagami, Eleonora Nicolò, Chiara Corti, et al.
Current Oncology Reports
|
March 19, 2022
Bystander effect of antibody-drug conjugates: fact or fiction?
Federica Giugliano, Chiara Corti, Paolo Tarantino, et al.
Aging Clinical and Experimental Research
|
May 20, 2017
Excess mortality in 2015: a time series and cause-of-death analysis in Northern Italy
Ugo Fedeli, Giulia Capodaglio, Elena Schievano, et al.
Lancet Regional Health. Americas
|
August 30, 2023
Broadening the scope of artificial intelligence in oncology
Revathi Ravella, Edward Christopher Dee, Chiara Corti, et al.
Current Treatment Options in Oncology
|
March 27, 2023
HER2-Low Breast Cancer: a New Subtype?
Chiara Corti, Federica Giugliano, Eleonora Nicolò, et al.
Immunotargets and Therapy
|
April 8, 2025
Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer
Chiara Corti, Beyza Koca, Tasnim Rahman, et al.
Expert Opinion on Investigational Drugs
|
March 21, 2022
CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress
Chiara Corti, Konstantinos Venetis, Elham Sajjadi, et al.
Pharmaceuticals (Basel, Switzerland)
|
September 28, 2021
Research and Clinical Landscape of Bispecific Antibodies for the Treatment of Solid Malignancies
Gabriele Antonarelli, Federica Giugliano, Chiara Corti, et al.
Expert Opinion on Biological Therapy
|
June 24, 2024
Checkpoint inhibition for early-stage hormone receptor-positive breast cancer
Ilana Schlam, Chiara Corti, Sarah Sammons, et al.
Page
of 14
Search research articles
Search
Showing results (11-20 of 133) with videos related to
Sort By:
Page
of 14
Cancers
|
July 2, 2021
Antibody-Drug Conjugates for the Treatment of Breast Cancer
Chiara Corti, Federica Giugliano, Eleonora Nicolò, et al.
Cancer Treatment and Research
|
January 4, 2024
New Concepts in Cardio-Oncology
Paola Zagami, Eleonora Nicolò, Chiara Corti, et al.
Current Oncology Reports
|
March 19, 2022
Bystander effect of antibody-drug conjugates: fact or fiction?
Federica Giugliano, Chiara Corti, Paolo Tarantino, et al.
Aging Clinical and Experimental Research
|
May 20, 2017
Excess mortality in 2015: a time series and cause-of-death analysis in Northern Italy
Ugo Fedeli, Giulia Capodaglio, Elena Schievano, et al.
Lancet Regional Health. Americas
|
August 30, 2023
Broadening the scope of artificial intelligence in oncology
Revathi Ravella, Edward Christopher Dee, Chiara Corti, et al.
Current Treatment Options in Oncology
|
March 27, 2023
HER2-Low Breast Cancer: a New Subtype?
Chiara Corti, Federica Giugliano, Eleonora Nicolò, et al.
Immunotargets and Therapy
|
April 8, 2025
Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer
Chiara Corti, Beyza Koca, Tasnim Rahman, et al.
Expert Opinion on Investigational Drugs
|
March 21, 2022
CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress
Chiara Corti, Konstantinos Venetis, Elham Sajjadi, et al.
Pharmaceuticals (Basel, Switzerland)
|
September 28, 2021
Research and Clinical Landscape of Bispecific Antibodies for the Treatment of Solid Malignancies
Gabriele Antonarelli, Federica Giugliano, Chiara Corti, et al.
Expert Opinion on Biological Therapy
|
June 24, 2024
Checkpoint inhibition for early-stage hormone receptor-positive breast cancer
Ilana Schlam, Chiara Corti, Sarah Sammons, et al.
Page
of 14